Mrv1909 12232016152 d 12 13 0 0 0 0 999 V2000型2.7308 -3.2309 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.9058 -3.2309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6509 -2.4463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3183 -1.9614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3183 -1.1364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6039 -0.7239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6039 0.1011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9364 0.5861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1914 1.3707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0164 1.3707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2713 0.5861 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 2.9858 -2.4463 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 4 0 0 0 0 3 1 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 6 7 1 0 0 0 0 7 8 2 0 0 0 0 8 9 1 0 0 0 0 9 10 2 0 0 0 0 10 11 1 0 0 0 0 7 11 1 0 0 0 0 4 12 12 2 0 0 0 0 1 1 0 0 0 0 M >结束
DB16397 >
drugbank >
N1C = CC (\ C = C \ C2 = CC = CS2) = N1 >
InChI = 1 s / C9H8N2S c1-2-9 (12-7-1) 4-3-8-5-6-10-11-8 / h1-7H (H、10、11) / b4-3 + >
FOHWAQGURRYJFK-ONEGZZNKSA-N >
C9H8N2S >
176.24 >
176.04081944 >
1 >
20 >
5.51438579493569 e-05 >
18.797081320982457 >
1 >
1 >
0 >
1 >
3 - [(1 e) 2 - (thiophen-2-yl)乙烯基]1 h-pyrazole >
2.78 >
2.7638133243333334 >
-2.70 >
0 >
0 >
2 >
0 >
14.843069070817362 >
2.7416341239436433 >
28.68 >
51.643 >
2 >
1 >
3.54 e-01 g / l >
N - {4 - [(2 s) 2 - [(2 s) 2 - [(methoxycarbonyl)氨基]3-phenylpropanamido] 2 - [2 - (thiophen-2-yl) 1, 3-thiazol-4-yl]乙基]苯基}氨基磺酸>
1 >
DB16397 >
临床实验的>
Terevalefim >
Refanalin;Terevalefim $ $ $ $